DSpace Repository

Anticancer Activities of Thiosemicarbazides/Thiosemicarbazones: A Review

Show simple item record

dc.contributor.author Arora, Shefali
dc.contributor.author Agarwal, Shilpi
dc.contributor.author Singhal, Shailey
dc.date.accessioned 2015-03-13T08:07:44Z
dc.date.available 2015-03-13T08:07:44Z
dc.date.issued 2014
dc.identifier.citation International Journal of Pharmacy and Pharmaceutical Sciences, Vol 6, Issue 9, 2014 en_US
dc.identifier.issn 0975-1491
dc.identifier.uri http://hdl.handle.net/123456789/1903
dc.description.abstract There have been tremendous development in the chemotherapy of cancer and researches are still developing new and more effective drugs to combat this disease. Thiosemicarbazides and thiosemicarbazone possess a wide range of biological applications. This key biological role is often related with their capability to inhibit the enzyme ribonucleotide reductase, similar to what is observed with potent anticancer drugs such as triapine and methisazone. Recent studies have revealed that thiosemicarbazones can inhibit topoisomerase II enzyme. This review discusses current advances of an emerging ‘new wave’ of thiosemicarbazide/thiosemicarbazone and their metal complexes as potent anticancer agents, mode of action and toxicity caused by them. en_US
dc.subject Medical Science en_US
dc.title Anticancer Activities of Thiosemicarbazides/Thiosemicarbazones: A Review en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account